Authors:
KYRLE PA
MANNHALTER C
BEGUIN S
STUMPFLEN A
HIRSCHL M
WELTERMANN A
STAIN M
BRENNER B
SPEISER W
PABINGER I
LECHNER K
EICHINGER S
Citation: Pa. Kyrle et al., CLINICAL-STUDIES AND THROMBIN GENERATION IN PATIENTS HOMOZYGOUS OR HETEROZYGOUS FOR THE G20210A MUTATION IN THE PROTHROMBIN GENE, Arteriosclerosis, thrombosis, and vascular biology, 18(8), 1998, pp. 1287-1291
Authors:
HELLAN M
KUHNEL E
SPEISER W
LECHNER K
EICHINGER S
Citation: M. Hellan et al., FAMILIAL LUPUS ANTICOAGULANT - A CASE-REPORT AND REVIEW OF THE LITERATURE, Blood coagulation & fibrinolysis, 9(2), 1998, pp. 195-200
Authors:
WELTERMANN A
PABINGER I
GEISSLER K
JAGER U
GISSLINGER H
KNOBL P
EICHINGER S
KYRLE PA
VALENT P
SPEISER W
SCHWARZINGER I
MANNHALTER C
LECHNER K
Citation: A. Weltermann et al., HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS, Leukemia, 12(8), 1998, pp. 1182-1186
Authors:
KAPIOTIS S
JILMA B
PERNERSTORFER T
STOHLAWETZ P
EICHLER HG
SPEISER W
Citation: S. Kapiotis et al., PLASMA-LEVELS OF ACTIVATED FACTOR-VII DECREASE DURING THE MENSTRUAL-CYCLE, Thrombosis and haemostasis, 80(4), 1998, pp. 588-591
Authors:
KOZEKLANGENECKER SA
KETTNER SC
OISMUELLER C
GONANO C
SPEISER W
ZIMPFER M
Citation: Sa. Kozeklangenecker et al., ANTICOAGULATION WITH PROSTAGLANDIN E-1 AND UNFRACTIONATED HEPARIN DURING CONTINUOUS VENOVENOUS HEMOFILTRATION, Critical care medicine, 26(7), 1998, pp. 1208-1212
Authors:
WELTERMANN A
MITTERBAUER GJ
MITTERBAUER M
HATTEY E
SPEISER W
GISSLINGER H
KNOBL P
EICHINGER S
Citation: A. Weltermann et al., DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT), Wiener Klinische Wochenschrift, 110(2), 1998, pp. 53-57
Authors:
HOFBAUER R
HOFBAUER L
MOSER D
SALFINGER H
SPEISER W
FRASS M
KAPIOTIS S
Citation: R. Hofbauer et al., LEUKOCYTE MIGRATION - A NEW TRIPLE MIGRATION CHAMBER ASSAY ALLOWS INVESTIGATION OF VARIOUS CELL-INTERACTIONS SIMULTANEOUSLY, Life sciences (1973), 63(19), 1998, pp. 1725-1737
Authors:
RUZICKA K
WOJTA J
ARTEMIOU O
BIRSAN T
QUEHENBERGER P
KAPIOTIS S
HOFBAUER R
SPEISER W
Citation: K. Ruzicka et al., HUMAN ENDOTHELIAL-CELLS DO NOT EXERT HEPARIN-LIKE ACCELERATING EFFECTS ON THROMBIN-ANTITHROMBIN-COMPLEX FORMATION, Life sciences (1973), 63(17), 1998, pp. 1493-1503
Authors:
QUEHENBERGER P
BIERHAUS A
FASCHING P
SPEISER W
NAWROTH PP
Citation: P. Quehenberger et al., INCREASED ENDOTHELIN-1 LEVELS THROUGH INTERACTION OF RED-BLOOD-CELLS WITH ENDOTHELIAL-CELLS, British Journal of Haematology, 102(1), 1998, pp. 300-301
Authors:
QUEHENBERGER P
LONER U
KAPIOTIS S
HANDLER S
SCHNEIDER B
HUBER J
SPEISER W
Citation: P. Quehenberger et al., EFFECTS OF 3RD-GENERATION ORAL-CONTRACEPTIVES CONTAINING NEWLY DEVELOPED PROGESTAGENS ON FIBRINOLYTIC PARAMETERS, Fibrinolysis & proteolysis, 11(2), 1997, pp. 97-101
Authors:
KAPIOTIS S
JILMA B
SZALAY T
DIRNBERGER E
WAGNER O
EICHLER HG
SPEISER W
Citation: S. Kapiotis et al., EVIDENCE AGAINST AN EFFECT OF ENDOTHELIN-1 ON BLOOD-COAGULATION, FIBRINOLYSIS, AND ENDOTHELIAL-CELL INTEGRITY IN HEALTHY-MEN, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 2861-2867
Authors:
NOVACEK G
KAPIOTIS S
MOSER G
SPEISER W
GANGL A
VOGELSANG H
Citation: G. Novacek et al., NO EVIDENCE OF ACTIVATED BLOOD-COAGULATION IN CROHNS-DISEASE, European journal of gastroenterology & hepatology, 9(10), 1997, pp. 963-967
Authors:
QUEHENBERGER P
BIERHAUS A
FASCHING P
MULLNER C
SPEISER W
ZIEGLER R
NAWROTH PP
Citation: P. Quehenberger et al., INDUCTION OF ENDOTHELIN-1 THROUGH ERYTHROCYTES OF PATIENTS WITH DIABETES-MELLITUS, Thrombosis and haemostasis, 1997, pp. 1872-1872
Authors:
KYRLE PA
STUMPFLEN A
HIRSCHL M
BIALONCZYK C
HERKNER K
SPEISER W
WELTERMANN A
KAIDER A
PABINGER I
LECHNER K
EICHINGER S
Citation: Pa. Kyrle et al., LEVELS OF PROTHROMBIN FRAGMENT F1+2 IN PATIENTS WITH HYPERHOMOCYSTEINEMIA AND A HISTORY OF VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 78(5), 1997, pp. 1327-1331
Authors:
JILMA B
DIRNBERGER E
EICHLER HG
MATULLA B
SCHMETTERER L
KAPIOTIS S
SPEISER W
WAGNER OF
Citation: B. Jilma et al., PARTIAL BLOCKADE OF NITRIC-OXIDE SYNTHASE BLUNTS THE EXERCISE-INDUCEDINCREASE OF VON-WILLEBRAND-FACTOR ANTIGEN AND OF FACTOR-VIII IN MAN, Thrombosis and haemostasis, 78(4), 1997, pp. 1268-1271
Authors:
KYRLE PA
EICHINGER S
PABINGER I
STUMPFLEN A
HIRSCHL M
BIALONCZYK C
SCHNEIDER B
MANNHALTER C
MELICHART M
TRAXLER G
WELTERMANN A
SPEISER W
LECHNER K
Citation: Pa. Kyrle et al., PROTHROMBIN FRAGMENT F1+2 IS NOT PREDICTIVE FOR RECURRENT VENOUS THROMBOEMBOLISM, Thrombosis and haemostasis, 77(5), 1997, pp. 829-833
Authors:
KYRLE PA
BROCKMEIER J
WELTERMANN A
EICHINGER S
SPEISER W
LECHNER K
EICHLER HG
Citation: Pa. Kyrle et al., INHIBITION RATHER THAN ENHANCEMENT OF HEMOSTATIC SYSTEM ACTIVATION DURING INITIATION OF ORAL ANTICOAGULANT TREATMENT, Thrombosis and haemostasis, 77(4), 1997, pp. 685-689
Authors:
NOVACEK G
KAPIOTIS S
JILMA B
QUEHENBERGER P
MICHITSCH A
TRAINDL O
SPEISER W
Citation: G. Novacek et al., ENHANCED BLOOD-COAGULATION AND ENHANCED FIBRINOLYSIS DURING HEMODIALYSIS WITH PROSTACYCLIN, Thrombosis research, 88(3), 1997, pp. 283-290
Authors:
RUZICKA K
KAPIOTIS S
QUEHENBERGER P
HANDLER S
PABINGERFASCHING I
MANNHALTER C
JILMA B
SPEISER W
Citation: K. Ruzicka et al., EVALUATION OF A NEW SCREENING ASSAY PROC(R) GLOBAL FOR IDENTIFICATIONOF DEFECTS IN THE PROTEIN-C PROTEIN-S ANTICOAGULANT PATHWAY, Thrombosis research, 87(6), 1997, pp. 501-510
Authors:
RUZICKA K
KAPIOTIS S
QUEHENBERGER P
HANDLER S
HORNYKEWYCZ S
MICHITSCH A
HUBER K
CLEMENS D
SUSAN M
PABINGER I
EICHINGER S
JILMA B
SPEISER W
Citation: K. Ruzicka et al., EVALUATION OF BEDSIDE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENT BY COAGULATION ANALYZER COAGUCHEK PLUS(R) IN VARIOUS CLINICAL SETTINGS, Thrombosis research, 87(5), 1997, pp. 431-440
Authors:
KAPIOTIS S
JILMA B
QUEHENBERGER P
RUZICKA K
HANDLER S
SPEISER W
Citation: S. Kapiotis et al., MORNING HYPERCOAGULABILITY AND HYPOFIBRINOLYSIS - DIURNAL-VARIATIONS IN CIRCULATING ACTIVATED FACTOR-VII, PROTHROMBIN FRAGMENT F1-PLASMIN INHIBITOR-COMPLEX(2, AND PLASMIN), Atherosclerosis, 134(1-2), 1997, pp. 192-192
Authors:
KAPIOTIS S
JILMA B
QUEHENBERGER P
RUZICKA K
HANDLER S
SPEISER W
Citation: S. Kapiotis et al., MORNING HYPERCOAGULABILITY AND HYPOFIBRINOLYSIS - DIURNAL-VARIATIONS IN CIRCULATING ACTIVATED FACTOR-VII, PROTHROMBIN FRAGMENT F1-PLASMIN INHIBITOR COMPLEX(2, AND PLASMIN), Circulation, 96(1), 1997, pp. 19-21
Authors:
JILMA B
EICHLER HG
STOHLAWETZ P
PERNERSTORFER T
SPEISER W
KAPIOTIS S
KALHS P
Citation: B. Jilma et al., PARTIAL BLOCKADE OF NITRIC-OXIDE SYNTHASE BLUNTS THE EXERCISE-INDUCEDINCREASE OF VON-WILLEBRAND-FACTOR ANTIGEN AND OF FACTOR-VIII IN MAN, Blood, 90(10), 1997, pp. 3047-3047